Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Zavegepant 5 mg	418
Overall Study	STARTED	Zavegepant 10 mg	417
Overall Study	STARTED	Zavegepant 20 mg	418
Overall Study	STARTED	Placebo	420
Overall Study	Treated	Zavegepant 5 mg	388
Overall Study	Treated	Zavegepant 10 mg	394
Overall Study	Treated	Zavegepant 20 mg	403
Overall Study	Treated	Placebo	403
Overall Study	Modified Intent-to-Treat (mITT) Participants	Zavegepant 5 mg	387
Overall Study	Modified Intent-to-Treat (mITT) Participants	Zavegepant 10 mg	391
Overall Study	Modified Intent-to-Treat (mITT) Participants	Zavegepant 20 mg	402
Overall Study	Modified Intent-to-Treat (mITT) Participants	Placebo	401
Overall Study	COMPLETED	Zavegepant 5 mg	386
Overall Study	COMPLETED	Zavegepant 10 mg	391
Overall Study	COMPLETED	Zavegepant 20 mg	399
Overall Study	COMPLETED	Placebo	402
Overall Study	NOT COMPLETED	Zavegepant 5 mg	32
Overall Study	NOT COMPLETED	Zavegepant 10 mg	26
Overall Study	NOT COMPLETED	Zavegepant 20 mg	19
Overall Study	NOT COMPLETED	Placebo	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03872453/flow